STEPHANIE WHIPPLE: Open Payments
NPI 1225475239 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 14 payments from 6 companies in 2025. Trend: 2023 $56 · 2024 $190 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $77 |
| Novo Nordisk Inc | 4 | $64 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Lilly USA, LLC | 2 | $49 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Medtronic, Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, GARDASIL 9, Ozempic, Rybelsus, KISUNLA, GEMTESA, MOUNJARO, VENASEAL.
Industry payments across FL — which companies pay providers there.
